Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Two eggs a day for healthier babies? new study tests simple fix for malnutrition

NCT ID NCT06405360

Prevention Sponsor: University of Florida Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 07, 2026 · Updated 3 times

Summary

This study tests whether pregnant women who eat two eggs daily have babies with longer birth lengths and better development. Researchers in Rwanda are giving eggs to some women and comparing them to those eating their usual diet. The goal is to see if this simple, affordable food can improve child growth and brain development.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
eggs
What this could lead to
If it works, this could show that a simple, affordable food like eggs can help prevent poor growth and development in babies.
What could go wrong
This is a single trial in one region of Rwanda, so results may not apply elsewhere. The effect on birth length may be small or not significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

464 people

The number who actually took part.

Started

May 2024

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 44 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Lives in study area (catchment area of Karangazi Health Center and Ndama Health Center) * Confirmed viable intrauterine pregnancy (confirmed via ultrasound) * Aged between 18-44 years * 9-14 weeks gestation (confirmed via ultrasound, up to 13 weeks +6 days) * Agrees to participate with informed consent Exclusion Criteria: * Intention to move outside the study area in next 12 months * Intention to deliver at a location outside of Eastern Province Nyagatare District * Any known adverse reaction to eating eggs or porridge ingredients * Any condition that could affect the ability to comply with the study requirements or understand the informed consent process * Participation in other clinical trials (to avoid burden and potential interactions between interventions) * Any individual unable or unwilling to comply with the study requirements, such as attending regular follow-up visits or adhering to prescribed nutritional supplementation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fetal growth retardation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

fetal growth restriction Infant Nutrition Disorders nutritional deficiency disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fetal growth retardation Infant malnutrition

Contacts and locations

Locations

  • Ndama Health Center

    Nyagatare, Rwanda

More trials for these conditions

Other studies related to the condition(s) this trial covers.